Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Severity of Psoriasis in Tunisia: Cross-Sectional Results From the National PsoTReg Registry.

International journal of dermatology·2026
Same author

Protective Role of <i>Ziziphus lotus</i> Fruits and Leaves Extracts Towards BPA-Associated Testis Toxicity.

Food science & nutrition·2026
Same author

Bridging Theory and Practice: Patho-Play as an Innovative Serious Game for Pathology Training in Medical Education.

La Tunisie medicale·2026
Same author

Spesolimab for generalized pustular psoriasis: A prospective study with a 6-month-follow-up.

Clinical and experimental dermatology·2026
Same author

Atypical Presentation of Grade III Hand-Foot Syndrome in a Patient With Breast Cancer Receiving Docetaxel.

American journal of therapeutics·2026
Same author

Fine needle aspiration cytology in the diagnosis of thyroid nodules.

La Tunisie medicale·2026

Related Experiment Video

Updated: Aug 4, 2025

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts
07:18

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts

Published on: June 13, 2019

7.0K

Exceptional outcome in cutaneous myeloid sarcoma.

Faten Hayder1, Anissa Zaouak1, Refka Frioui1

  • 1Department of Dermatology Habib Thameur Hospital Tunis Tunisia.

Clinical Case Reports
|March 31, 2023
PubMed
Summary

Recognizing cutaneous myeloid sarcoma is crucial for dermatologists to prevent acute myeloid leukemia progression. Some patients experience spontaneous regression, indicating a favorable clinical outcome.

Area of Science:

  • Dermatology
  • Hematology
  • Oncology

Background:

  • Cutaneous myeloid sarcoma (CMS) is a rare extramedullary manifestation of myeloid neoplasms.
  • Early recognition of CMS is vital to prevent progression to acute myeloid leukemia (AML).
Keywords:
dermatologyhematologyoncology

More Related Videos

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma
07:55

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

Published on: April 11, 2018

14.4K
Surgical Transplantation of Tumor Cells into the Spinal Cord of Mice
05:39

Surgical Transplantation of Tumor Cells into the Spinal Cord of Mice

Published on: December 27, 2024

504

Related Experiment Videos

Last Updated: Aug 4, 2025

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts
07:18

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts

Published on: June 13, 2019

7.0K
Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma
07:55

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

Published on: April 11, 2018

14.4K
Surgical Transplantation of Tumor Cells into the Spinal Cord of Mice
05:39

Surgical Transplantation of Tumor Cells into the Spinal Cord of Mice

Published on: December 27, 2024

504